Polish pharmaceutical company LEK-AM says there are “saddened” to hear what happened after Iga Swiatek consumed one of their manufactured pills but also denied that they failed to respond to the ITIA when contacted.
On Thursday, the tennis world was stunned by the news of the five-time Grand Slam champion failing a doping test and accepting a one-month ban. In a detailed announcement, it was explained that the 23-year-old tested positive for trimetazidine (TMZ), which she ingested after taking melatonin medication to treat stress and sleep issues.
After provisionally being suspended and later allowed to return to action after determining the source of contamination, Swiatek’s one-month ban started on November 27 – but the Pole only had eight more days to serve since she served 22 during her provisional suspension.
In her message, the Polish tennis superstar said it was “the toughest battle of her life” and something that left her feeling very anxious and gave sleepless nights.
Since she has been one of the top and most successful Polish athletes for a couple of years now, the company that manufactured the medication received certain criticism and backlash in Poland.
“Like the international public opinion and fans of Ms. Iga Swiatek, we are saddened by the situation…
